Most data on the prevalence of NF2 mutations and 22q loss in spinal ependymal tumors were generated prior to the identification of distinct molecular ependymoma types and therefore show varying frequencies of these driver events [5, 13, 28, 42]. This evidence concerns the gene NF2 and ependymal tumor.